A US FDA-approved, closed-loop neuromodulation system (RNS, NeuroPace) for medically refractory focal onset epilepsy is to be evaluated for managing loss-of-control eating in patients with body mass index (BMI) of 45-60 kg/m2 for whom medication and gastric bypass surgery have not been effective treatments and for whom loss-of-control eating is a contributing factor. A [...]